Aspirin for Primary Prevention of CV Events in Relation to Lp(a) Genotypes
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Aspirin for Primary Prevention of Cardiovascular Events in Relation to Lipoprotein(a) Genotypes
J Am Coll Cardiol 2022 Oct 04;80(14)1287-1298, P Lacaze, A Bakshi, M Riaz, G Polekhina, A Owen, HS Bhatia, P Natarajan, R Wolfe, L Beilin, SJ Nicholls, GF Watts, JJ McNeil, AM Tonkin, S TsimikasFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.